Search clinical trials for: OPC-214870

Total 961 results

Radboud University Medical Center

Completed

The Impact of Age and Fitness on Reperfusion Injury and Ischemic Preconditioning to Prevent This Injury

Cardiovascular Disease

Netherlands
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Recruiting

CNS10-NPC for the Treatment of RP

Retinitis Pigmentosa

United States
Scientific Laboratory Products, Ltd.

Completed

Comparing the Sleep Strip OTC™ Accuracy in Screening for Sleep Apnea Syndrome Against the Reference Method, an In-lab Full Night Polysomnographic (PSG)

Sleep Apnea Syndrome

Israel
Institut Paoli-Calmettes

Not yet recruiting

Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment (E-SN@P PROJECT)

Breast Cancer | Colorectal Cancer | Lung Cancer

France
Optinose US Inc.

Recruiting

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Bilateral Nasal Polyposis

United States
Karolinska University Hospital
Istituto Ortopedico Rizzoli; Sahlgrenska University Hospital, Sweden; University... and other collaborators

Recruiting

Swedish Multicenter Trial of Outpatient Prevention of Leg Clots (StopLegClots)

Venous Thromboembolism | Ankle Fractures | Achilles Tendon Rupture

Sweden
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, United Kingdom, Bulgaria, Canada, Georgia, Poland, Russian Federation, Sweden
University of Miami
Arthrex, Inc.

Completed

Clinical Outcomes of ACL Reconstruction Augmented by an Injectable Osteoconductive/Osteoinductive Compound

ACL Injury

United States
Lineage Cell Therapeutics, Inc.

Completed

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

Cervical Spinal Cord Injury | Spine Injury | Spinal Cord Trauma

United States
Oppilan Pharma Ltd
Celerion

Completed

A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers

Healthy

United Kingdom
Hospital Universitario 12 de Octubre
Apices Soluciones S.L.; Otsuka Pharmaceutical Co., Ltd.; Vivia Biotech

Completed

Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia

Acute Myeloid Leukemia

Spain
Mathematica Policy Research, Inc.
Centers for Medicare and Medicaid Services

Enrolling by invitation

Evaluation of the Comprehensive Primary Care Plus (CPC+) Model

All Conditions
Otsuka Pharmaceutical Co., Ltd.

Completed

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Acute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid Leukemia

Japan
Myrexis Inc.

Terminated

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Alzheimer's Disease

United States, Canada
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Non-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)

Hong Kong
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Melcap Systems Ltd.

Suspended

Safety and Feasibility Assessment of the Bio-electrical One Day Capsule System in Overweight and Class I Obese Participants

Overweight and Obesity

Israel
Assiut University

Not yet recruiting

Mandibular Dimensions as a Predictor of Age and Sex in a Sample of Upper Egypt Population by Using Panoramic Images and Cone Beam Computed Tomography

Mandibular Dimensions
Boston Children's Hospital
The Hospital for Sick Children; Yale University; CURE Children's Hospital, Uganda

Recruiting

Improving Infant Hydrocephalus Outcomes in Uganda

Hydrocephalus

Canada, United States, Uganda
Erchonia Corporation

Completed

Human Factors Testing for OTC Use of the Erchonia® LunulaLaser

Onychomycosis

United States
Queen's University, Belfast
Innovate UK; Northern Ireland Clinical Trials Unit

Active, not recruiting

Clinical Evaluation of a Point of Care (POC) Assay to Identify Phenotypes in the Acute Respiratory Distress Syndrome (PHIND)

Acute Respiratory Distress Syndrome (ARDS)

United Kingdom, Ireland
University of Regensburg

Completed

OFC rTMS in Emotionally Unstable and Depressed Patients (ORIENT)

Depression | Personality Disorder, Borderline | Personality Disorder; Unstable

Germany
Optinose US Inc.

Terminated

A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19

Covid19

Mexico
Fabio Garofalo

Withdrawn

A Study to Reduce the Reflux After a Sleeve Gastrectomy in Obese Patients

Obesity | Gastroesophageal Reflux

Switzerland
Nobelpharma

Terminated

Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer

Neuropathic Pain in Cancer

Japan
Chase Pharmaceuticals Corporation, an affiliate...

Completed

A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia

Alzheimer's Disease

United States
Assiut University

Unknown

Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy

Diabetic Nephropathies | Vascular Calcification

Egypt
Clinton Health Access Initiative Inc.
UNICEF; Ministry of Health, Malawi

Completed

Point of Care Early Infant Diagnosis Patient Impact Study

HIV

Malawi
Chase Pharmaceuticals Corporation, an affiliate...

Completed

Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07

Dementia of the Alzheimer's Type

United States
Optimer Pharmaceuticals LLC

Completed

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Diarrhea

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer

Solid Tumors

United States
Soroka University Medical Center

Unknown

The Use of Point of Care Ultra Sound for Correct Placement of Central Venous Catheter

Central Venous Catheter

Israel
Adamis Pharmaceuticals Corporation

Unknown

Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer

Prostate Cancer

United States
Otsuka Beijing Research Institute

Completed

Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Singapore
Korea Otsuka Pharmaceutical Co., Ltd.

Unknown

An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

Solid Tumor

Korea, Republic of
Myrexis Inc.

Completed

Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases

Brain Neoplasms

United States
M.D. Anderson Cancer Center
CareFusion

Active, not recruiting

Intrapleural Catheter Daily Versus Three Times a Week Drainage

Advanced Cancer | Pleural Effusion

United States
Laboratorios de Biologicos y Reactivos de México...

Unknown

Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns

Poliomyelitis

Mexico
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
Boston Children's Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

NIRS Monitoring in Premature Infants

Hemorrhage | Premature Infants | Newborn | Hydrocephalus

United States
University of Pennsylvania

Active, not recruiting

Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease

Peripheral Artery Disease

United States
University Hospital Tuebingen

Terminated

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

Leishmaniasis

Germany
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, Australia, Poland, New Zealand, Spain, Georgia, United Kingdom, Bulgaria, Czechia, Romania
Hadassah Medical Organization

Unknown

Using Travelan to Boost Immune Response in Vitro to COVID-19

Covid19

Israel
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor

Solid Tumor

Korea, Republic of
Opsona Therapeutics Ltd.
M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaborators

Completed

A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Opsona Therapeutics Ltd.
M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaborators

Completed

Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
National University Hospital, Singapore
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase IIa Dose-Expansion and Biomarker Study of OPB-111077

NPC | Refractory Tumor

Singapore
Korea Otsuka Pharmaceutical Co., Ltd.

Terminated

A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)

Advanced Hepatocellular Carcinoma

Korea, Republic of
Otsuka Novel Products GmbH

Terminated

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

Breast Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Salivary Gland Cancer | Squamous Cell Carcinoma of the Cervix

United Kingdom

Search clinical trials for: OPC-214870

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations